These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34097810)

  • 1. Selective Bacterial Targeting and Infection-Triggered Release of Antibiotic Colistin Conjugates.
    Tegge W; Guerra G; Höltke A; Schiller L; Beutling U; Harmrolfs K; Gröbe L; Wullenkord H; Xu C; Weich H; Brönstrup M
    Angew Chem Int Ed Engl; 2021 Aug; 60(33):17989-17997. PubMed ID: 34097810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
    Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Yokota SI; Hakamada H; Yamamoto S; Sato T; Shiraishi T; Shinagawa M; Takahashi S
    Int J Antimicrob Agents; 2018 Jun; 51(6):888-896. PubMed ID: 29432867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical synthesis of isoindolines yields potent colistin potentiators for multidrug-resistant
    Dutta S; Eyolfson S; Zhu Y; Gao Y; Wang X
    Org Biomol Chem; 2024 May; 22(20):4057-4061. PubMed ID: 38716633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates.
    Borrego-Jiménez J; Soria-Segarra C; Moldovan TD; Navarro-Marí JM; Gutiérrez-Fernández J
    Rev Esp Quimioter; 2020 Feb; 33(1):83-84. PubMed ID: 31895527
    [No Abstract]   [Full Text] [Related]  

  • 7. Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.
    Matzneller P; Strommer S; Österreicher Z; Mitteregger D; Zeitlinger M
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1989-94. PubMed ID: 26178070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid screening of colistin-resistant Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa by the use of Raman spectroscopy and hierarchical cluster analysis.
    Lin Z; Zhao X; Huang J; Liu W; Zheng Y; Yang X; Zhang Y; Lamy de la Chapelle M; Fu W
    Analyst; 2019 Apr; 144(8):2803-2810. PubMed ID: 30882113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performances of the Rapid Polymyxin
    Lescat M; Poirel L; Jayol A; Nordmann P
    Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
    [No Abstract]   [Full Text] [Related]  

  • 10. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y; Wang R; Liang BB; An MM
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.
    Azzopardi EA; Ferguson EL; Thomas DW
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1837-43. PubMed ID: 25512401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined colistin and meropenem against meropenem resistant
    Gunalan A; Sarumathi D; Sastry AS; Ramanathan V; Rajaa S; Sistla S
    Indian J Pharmacol; 2021; 53(3):207-212. PubMed ID: 34169905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA; Lin G; Seifert H; Appelbaum PC
    Antimicrob Agents Chemother; 2008 Jan; 52(1):333-6. PubMed ID: 17967915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Ko KS
    J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
    Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
    Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin Binding Reduces Colistin Antimicrobial Activity.
    Huang JX; Blaskovich MA; Pelingon R; Ramu S; Kavanagh A; Elliott AG; Butler MS; Montgomery AB; Cooper MA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5925-31. PubMed ID: 26169405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G; Samlioglu P; Atalay S; Kose S
    Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.